MedPath

Efficacy and Safety of Fermented Cinnamon Vine Powder on Decrement of Body Fat

Not Applicable
Completed
Conditions
Obesity
Interventions
Dietary Supplement: Placebo
Dietary Supplement: Fermented Cinnamon Vine Powder
Registration Number
NCT01734187
Lead Sponsor
Chonbuk National University Hospital
Brief Summary

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Fermented Cinnamon Vine Powde on decrement of body fat. The investigators measured decrement of body fat parameters , including abdominal fat, Body Fat Mass, LDL-C, HDL-C, Total Cholesterol and triglyceride, and monitored their blood pressure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Males and females 19-55 years old
  • BMI(body mass index) ≥ 25 kg/m^2 or WC(Waist Circumference) ≥ 90(men), WC ≥ 85(women)
  • Able to give informed consent
Exclusion Criteria
  • Significant variation in weight(more 10%) in the past 3 months
  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
  • History of alcohol or substance abuse
  • Participation in any other clinical trials within past 2 months
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • Pregnant or lactating women etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo-
Fermented Cinnamon Vine PowderFermented Cinnamon Vine Powder-
Primary Outcome Measures
NameTimeMethod
Changes in Body Fat Mass12 weeks

Body Fat Mass was measured in study visit 1(0 week) and visit 3(12 week).

Changes in abdominal Fat12 weeks

Abdominal Fat was measured in study visit 1(0 week) and visit 3(12 week).

Secondary Outcome Measures
NameTimeMethod
Changes in LDL-cholesterol(Low Density Lipoprotein - Cholesterol)12 weeks

LDL-C(Low Density Lipoprotein - cholesterol) was measured in study visit 1(0 week) and visit 3(12 week).

Changes in HDL-Cholesterol(High Density Lipoprotein - Cholesterol)12 weeks

HDL-cholesterol(High Density Lipoprotein - cholesterol) was measured in study visit 1(0 week) and visit 3(12 week).

Changes in total cholesterol12 weeks

Total cholesterol was measured in study visit 1(0 week) and visit 3(12 week).

Changes in Triglycerides12 weeks

Triglyceride was measured in study visit 1(0 week) and visit 3(12 week).

Trial Locations

Locations (1)

Clinical Trial Center for Functional Foods; Chonbuk National University Hospital

🇰🇷

Jeonju, Jeollabuk-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath